We studied the effects of new water-soluble polysubstituted fullerene C60 (PFD) derivatives on activity of Ca2+-Mg2+ ATPase of the sarcoplasmic reticulum and cGMP phosphodiesterase. All examined fullerene derivatives inhibited activity of both enzymes. For instance, PFD-I, PFD-II, PFD-III, PFD-V, PFD-IX, PFD-X, and PFD-XI in a concentration of 5x10(-5) M completely inhibited hydrolytic and transport functions of Ca2+-ATPase. These compounds in a concentration of 5x10(-6) suppressed active transport of calcium ions by 51 +/- 5, 77 +/- 8, 52 +/- 5, 52 +/- 5, 100 +/- 10, 80 +/- 8, and 100 +/- 10%, respectively, and inhibited ATP hydrolysis by 31 +/- 3, 78 +/- 8, 18 +/- 2, 29 +/- 3, 78 +/- 8, 63 +/- 7, and 73 +/- 9%, respectively, uncoupling the hydrolytic and transport functions of the enzyme. PFD-I noncompetitive and reversibly reduced activity of Ca2+-ATPase (K-i=2.3x10(-6) M). All the studied fullerene derivatives (except for PFD-VII) inhibited cGMP phosphodiesterase by more than 80% in concentration of 10(-4) M and higher and by more than 50% in concentration of 10(-5) M. PFD-I is a non-competitive reversible inhibitor of cGMP phosphodiesterase (K-i=7x10(-6) M). These results allow us to expect antimetastatic, antiaggregatory, antihypertensive and vasodilative activity of the studied compounds.